126 related articles for article (PubMed ID: 382435)
1. The effect of low-dose heparin on fibrinopeptide A, platelets, fibrinogen degradation products and other haemostatic parameters measured in connection with intestinal surgery.
Törngren S; Norén I; Savidge G
Thromb Res; 1979; 14(6):871-9. PubMed ID: 382435
[No Abstract] [Full Text] [Related]
2. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
[TBL] [Abstract][Full Text] [Related]
3. Effect of anticoagulant treatment measured by fibrinopeptide A (fpA) in patients with venous thrombo-embolism.
Peuscher FW; van Aken WG; Flier OT; Stoepman-van Dalen EA; Cremer-Goote TM; van Mourik JA
Thromb Res; 1980 Apr 1-15; 18(1-2):33-43. PubMed ID: 7404504
[No Abstract] [Full Text] [Related]
4. Haemostatic abnormalities and outcome in patients with operable breast cancer.
McCulloch P; Lowe GD; Douglas JT; Murray GD; George WD
Eur J Cancer; 1990; 26(9):950-3. PubMed ID: 2149020
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
Widström O; Kockum C; Nilsson BS
Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
[TBL] [Abstract][Full Text] [Related]
6. [Role of proteases, plasminogen activators, fibrin fibrinogen degradation products and fibrinopeptides in the growth and development of neoplasms and neoplasm metastases].
Farbiszewski R
Postepy Hig Med Dosw; 1984; 38(2):133-55. PubMed ID: 6393101
[No Abstract] [Full Text] [Related]
7. Fibrinopeptide A and fibrinogen fragment B beta 15-42 and their relation to the operative trauma and post-operative thromboembolism in neurosurgical patients.
Boström S; Holmgren E; Jonsson O; Lindström B; Stigendal L
Acta Neurochir (Wien); 1987; 88(1-2):49-55. PubMed ID: 2447755
[TBL] [Abstract][Full Text] [Related]
8. Fibrin polymerization sites in fibrinogen and fibrin fragments.
Budzynski AZ; Olexa SA; Pandya BV
Ann N Y Acad Sci; 1983 Jun; 408():301-14. PubMed ID: 6575691
[No Abstract] [Full Text] [Related]
9. Progress in the measurement of circulating fibrinogen derivatives.
Wilner GD
Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
[No Abstract] [Full Text] [Related]
10. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
[TBL] [Abstract][Full Text] [Related]
12. Hypercoagulability.
Hirsh J
Semin Hematol; 1977 Oct; 14(4):409-25. PubMed ID: 72416
[No Abstract] [Full Text] [Related]
13. [In vivo behavior of soluble fibrin monomer after cleavage of fibrinopeptide A].
Müller-Berghaus G; Mahn I
Verh Dtsch Ges Inn Med; 1978; (84):1351-3. PubMed ID: 741964
[No Abstract] [Full Text] [Related]
14. Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.
Kang J; Kambayashi J; Sakon M; Tsujinaka T; Mori T
Jpn J Surg; 1989 May; 19(3):262-8. PubMed ID: 2674499
[TBL] [Abstract][Full Text] [Related]
15. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen derivatives in plasma.
Lane DA
Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635
[No Abstract] [Full Text] [Related]
17. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
Vila V; Regañón E; Aznar J; Navarro G; Salas M
Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261
[TBL] [Abstract][Full Text] [Related]
19. Fibrinopeptide release from fibrinogen Paris I.
Finlayson JS; Reamer LA; Mosesson MW; Menache D
Thromb Res; 1980 Feb 1-15; 17(3-4):577-9. PubMed ID: 7368177
[No Abstract] [Full Text] [Related]
20. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
